Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.17%
SPX
-0.06%
IXIC
-0.06%
FTSE
-0.39%
N225
0.00%
AXJO
-0.40%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
undefined
astx
Astex Pharmaceuticals
ASTX
+21.26 (+28.79%)
95.1
USD
At close at Jan 19, 21:37 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

Astex Pharmaceuticals Inc.: Innovating Biotech with Fragment-Based Drug Design and Strategic Partnerships

6 months ago
publisher logo
Cashu

Astex Pharmaceuticals Inc: Pioneering Innovative Drug Development in Oncology and Hematology

6 months ago
publisher logo
Cashu

Astex Pharmaceuticals Inc. Leverages AI Innovations for Drug Discovery and Competitive Advantage

6 months ago

Latest Astex Pharmaceuticals News

prnewswire.com

Options Trading Now Available on Latest Five Tradr ETFs: CWVX, SMU, ASTX, GEVX and CEGX

Feature Image for interests on Banking & Financial Services, Financial Technology, New Products & Services, Stock from prnewswire.com
6 months ago
benzinga.com

Tradr's New ETFs Are A Rebellion Against Boring Portfolios

Feature Image for interests on New Etfs, Space, Stock, Stories That Matter from benzinga.com
6 months ago
finance.yahoo.com

Astex Pharmaceuticals Announce Key Data Presentations at the 36th EORTC-NCI-AACR Symposium

Feature Image for interests on Astex Pharmaceuticals, Cambridge, Cbp, Hat from finance.yahoo.com
about 1 year ago
finance.yahoo.com

Novartis Kisqali shows deepening benefit in new analysis, reducing the risk of recurrence by 28.5% in a broad population of patients with early breast cancer

Feature Image for interests on Advanced Breast Cancer, Breast Cancer, Endocrine Therapy, Healthcare from finance.yahoo.com
over 1 year ago
businesswire.com

OpenFold AI Research Consortium Welcomes Six New Members: Astex, Biogen, Congruence, Polaris Quantum, Psivant, and SandboxAQ

Feature Image for interests on Healthcare, Stock, Technology, Unknown Sector from businesswire.com
over 1 year ago
businesswire.com

Electra Therapeutics Builds Leadership Team with Appointment of Dr. Graham Parry as Chief Scientific Officer and Dr. Kim-Hien Dao as Chief Medical Officer

Feature Image for interests on Stock, Unknown Sector from businesswire.com
over 1 year ago
finance.yahoo.com

Novartis highlights pioneering innovation in CML with data from Scemblix Phase III ASC4FIRST study in newly diagnosed patients at ASCO and EHA

Feature Image for interests on Abstract Number, American Society Of Clinical Oncology, Asco, Breast Cancer from finance.yahoo.com
over 1 year ago
finance.yahoo.com

Small Molecule Innovator API CDMO Research Report 2024: Global Market to Reach $47.14 Billion by 2030 driven by Increasing Demand for Small Molecule Drugs, and Surge in Clinical Trials

Feature Image for interests on Cdmo, Clinical Trials, Drug Development, Healthcare from finance.yahoo.com
over 1 year ago
finance.yahoo.com

Pheochromocytoma Pipeline Insight Report 2024, Featuring Genentech, Exelixis, Advanced Accelerator Applications, Enterome, FUJIFILM Toyama Chemical, Ipsen, Pfizer and Astex Pharmaceuticals

Feature Image for interests on Clinical Assessment, Clinical Development, Healthcare, Pheochromocytoma from finance.yahoo.com
almost 2 years ago
benzinga.com

Astex Pharmaceuticals Announce Key Data Presentations at the American Association For Cancer Research (AACR) 2024 Annual Meeting

almost 2 years ago
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.